Wedbush reiterated their outperform rating on shares of Nuvalent (NASDAQ:NUVL – Free Report) in a research note released on Friday morning, Benzinga reports. Wedbush currently has a $99.00 price objective on the stock. Other analysts have also issued reports about the stock. Jefferies Financial Group started coverage on shares of Nuvalent in a research note […]
Craig Hallum reissued their buy rating on shares of Celcuity (NASDAQ:CELC – Free Report) in a research note issued to investors on Thursday, Marketbeat.com reports. The firm currently has a $27.00 target price on the stock, up from their previous target price of $25.00. Several other research firms have also commented on CELC. Needham & […]